Group items tagged

"Analytical Tool - Breast Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in breast cancer R&D and business development.

"Analytical Tool - Pancreatic Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in pancreatic cancer R&D and business development. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. This tool provides you with an immense amount of information structured and analyzed to assist you in your work.

Product Synopsis IT Business Confidence Tracker Report Q4 2013 is a new report by Kable that globally analyzes industry opinions on the latest economic and customer issues, and their impact upon investment decisions and growth prospects within the IT industry. This report also examines the current and future state of economy and its retrospective effect on the industry.

This report provides readers with an excellent way of gaining an understanding of the dynamics and structure of premium beer category worldwide. Data includes volumes from 2008 to 2012 plus provisional data for 2013.

Research on India has announced the addition of "e-Tailing Market in India 2014"research report to their offering. The report titled e-tailing market in india 2014 captures the current scenario of the e-tailing market in india.

Research on India has announced the addition of "e-Commerce Market in India 2014"research report to their offering. The report titled e-commerce market in india 2014 captures the current scenario prevailing within the e-commerce market in india.

The report, power boilers, 2013 update - global market size, average pricing, equipment market share and competitive landscape analysis to 2020 provides detailed information on the current power boilers market, focusing on key countries as well as the global scenario.

The report provides an overview of the approved therapies for rrmm, ndmm, aml, mds, unmet need and limitations of the current soc for relapsed and refractory pts.

"Analytical Tool - Cancer Therapeutic Antibodies" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in antibody drug development for the treatment of cancer.